Latest News & Updates
Breaking News
10 minutes ago
Vaibhavi M.
Other trending news you may like to read
Novo Nordisk’s Phase 3 Evoke Trials Show Oral Semaglutide Does Not Slow Alzheimer’s Progression
Novo Nordisk’s phase 3 evoke trials show oral semaglutide did not slow Alzheimer’s progression, despite positive biomarker changes and consistent safety results.
Vaibhavi M.
Tonix Pharmaceuticals Wins FDA IND Clearance To Advance TNX-102 SL For Phase 2 HORIZON Study, Targeting Unmet Needs In Major Depressive Disorder
Tonix’s TNX-102 SL receives FDA IND clearance for Phase 2 testing in major depressive disorder, advancing a novel sleep-targeted approach to treating MDD.
Vaibhavi M.
Biogen And Dayra Therapeutics Launch Collaboration To Develop Oral Macrocyclic Peptides For Immunology; $50M Agreement Strengthens Biogen’s Immunology Pipeline
Biogen and Dayra Therapeutics partner to develop oral macrocyclic peptides for immunology, expanding Biogen’s pipeline with next-generation therapeutic candidates.
Vaibhavi M.
FDA Type B Meeting Supports Development Path For Plus Therapeutics’ Targeted Radiotherapy REYOBIQ In CNS Cancers
Plus Therapeutics completes FDA Type B meeting, advancing REYOBIQ toward a pivotal trial for leptomeningeal metastases, a rare and aggressive CNS cancer complication.
Vaibhavi M.
